Other languages Balaxi Pharmaceuticals Limited

Equities

BALAXI

INE618N01022

Market Closed - NSE India S.E. Other stock markets 07:43:51 2024-05-31 am EDT			5-day change	1st Jan Change
119 ^INR	-9.33%		-7.21%	+37.62%

May. 29	Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
May. 09	Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 29
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer	May. 09
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director	May. 08
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer	May. 04
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile	Feb. 14
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant	Feb. 09
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 02
Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.	23-09-30
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-03
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.	23-08-02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-29
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-01
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018	23-01-10
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-05
Balaxi Pharmaceuticals : Press Release	22-09-05
Balaxi Pharmaceuticals : Extra Ordinary Meeting	22-09-05
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-02
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-23
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Balaxi Pharmaceuticals Limited

Equities

BALAXI

INE618N01022

Other languages

Filters